PEROTTI, Paola Carla Giuseppina
 Distribuzione geografica
Continente #
NA - Nord America 2.180
EU - Europa 1.491
AS - Asia 628
SA - Sud America 132
AF - Africa 37
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.500
Nazione #
US - Stati Uniti d'America 2.115
IT - Italia 347
CN - Cina 240
SE - Svezia 172
DE - Germania 155
IE - Irlanda 138
FR - Francia 114
JP - Giappone 113
UA - Ucraina 96
GB - Regno Unito 63
VN - Vietnam 60
PL - Polonia 58
BE - Belgio 47
TR - Turchia 45
BR - Brasile 44
CA - Canada 44
ES - Italia 42
HU - Ungheria 42
AR - Argentina 40
AT - Austria 37
FI - Finlandia 35
IN - India 35
KR - Corea 35
GR - Grecia 30
AU - Australia 24
RU - Federazione Russa 24
CO - Colombia 19
MX - Messico 17
HK - Hong Kong 16
NL - Olanda 16
TW - Taiwan 14
DZ - Algeria 13
CH - Svizzera 12
DK - Danimarca 12
TH - Thailandia 12
PT - Portogallo 11
CL - Cile 10
IL - Israele 10
ZA - Sudafrica 10
MY - Malesia 9
SG - Singapore 8
PH - Filippine 7
RO - Romania 7
SI - Slovenia 7
EC - Ecuador 6
HR - Croazia 6
PE - Perù 6
NZ - Nuova Zelanda 5
BA - Bosnia-Erzegovina 4
JO - Giordania 4
SY - Repubblica araba siriana 4
TN - Tunisia 4
UZ - Uzbekistan 4
VE - Venezuela 4
CZ - Repubblica Ceca 3
EU - Europa 3
IR - Iran 3
MU - Mauritius 3
SK - Slovacchia (Repubblica Slovacca) 3
TZ - Tanzania 3
UY - Uruguay 3
DO - Repubblica Dominicana 2
EG - Egitto 2
ID - Indonesia 2
KZ - Kazakistan 2
LV - Lettonia 2
NO - Norvegia 2
RS - Serbia 2
SA - Arabia Saudita 2
SN - Senegal 2
BG - Bulgaria 1
BY - Bielorussia 1
KW - Kuwait 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
OM - Oman 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
Totale 4.500
Città #
Chandler 306
Fairfield 167
Dublin 136
Beijing 112
Ashburn 108
Houston 92
Woodbridge 86
Seattle 84
Ann Arbor 82
Cambridge 79
Redwood City 79
Torino 79
Wilmington 61
Nyköping 59
Jacksonville 50
Dong Ket 42
Medford 36
Pisa 36
Turin 35
Princeton 34
Vienna 31
Brussels 28
Würzburg 27
Budapest 26
Dearborn 23
Villeurbanne 23
Warsaw 23
Fremont 22
New York 21
Okazaki 21
Boston 20
Buenos Aires 16
Munich 16
Shanghai 15
Ankara 14
Milan 14
Paris 14
Tokyo 13
Athens 12
San Diego 12
Bogotá 11
Brescia 11
Guangzhou 11
Rochester 11
Moscow 10
Szekszárd 10
Chengdu 9
Fukuoka 9
Durham 8
Los Angeles 8
Polska 8
Soliera 8
Taipei 8
Delhi 7
Hangzhou 7
Katowice 7
Portland 7
Washington 7
Amsterdam 6
Bad Zwischenahn 6
Bozeman 6
Canberra 6
Düsseldorf 6
Gumyojicho 6
Hefei 6
Istanbul 6
Lima 6
Longueuil 6
Matawan 6
Nanjing 6
Naples 6
Norfolk 6
Pasto 6
Seoul 6
Silver Spring 6
Bangkok 5
Berlin 5
Boardman 5
Concepción 5
Edinburgh 5
Florianópolis 5
General Rodriguez 5
Hebei 5
Liège 5
Lublin 5
Madrid 5
Phoenix 5
San Francisco 5
Scott Depot 5
St. Petersburg 5
Tampa 5
Toronto 5
Baltimore 4
Bethesda 4
Brisbane 4
Central District 4
Curitiba 4
Erlangen 4
Florence 4
Fontenay-sous-bois 4
Totale 2.530
Nome #
New perspectives for mitotane treatment of adrenocortical carcinoma 920
18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma. 293
MITOTANE LEVELS PREDICT THE OUTCOME OF PATIENTS WITH ADRENOCORTICAL CARCINOMA TREATED ADJUVANTLY FOLLOWING RADICAL RESECTION. 286
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma. 282
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. 251
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma 228
Analysis of BCLI, N363S and ER22/23EK polymorphisms of the glucocorticoid receptor gene in adrenal incidentalomas 224
Determination of salivary cortisol to assess time related changes of the adrenal response to stress in critically ill patients 152
Differential expression of determinants of glucocorticoid sensitivity in androgen-dependent and androgen-independent human prostate cancer cell lines 144
Differential patterns of glucocorticoid receptors and 11beta hydroxysteroid dehydrogenase activity in androgen-dependent and androgen-independent prostate cancer cell lines. Relevance to glucocorticoid sensitivity. 113
CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells 111
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 108
Adrenocortical Carcinoma with Hypercortisolism. 106
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 104
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options. 103
Efficacy of repeat surgery in patients with recurrent adrenocortical cancer (ACC) 97
Mitotane concentrations influence outcome in patients with advanced adrenocortical carcinoma 95
Neuroendocrine immunity in patients with Alzheimer's disease: toward translational epigenetics 91
Physiologic modulation of natural killer cell activity as an index of Alzheimer's disease progression 88
Mitotane: new facts for an old drug 88
Unwanted hormonal and metabolic effects of postoperative adjuvant mitotane treatment for adrenocortical cancer 71
Changes in body composition after androgen deprivation therapy (ADT) in prostate cancer patients. Relationship with disease outcome 70
PREOPERATIVE TREATMENT WITH METYRAPONE IN PATIENTS WITH CUSHING'S SYNDROME DUE TO ADRENAL ADENOMA. 68
Aluminium blunts the proliferative response and increases apoptosis of cultured human cells: putative relationship to alzheimer's disease 64
Metronomic therapy concepts in the management of adrenocortical carcinoma. 54
A current perspective on treatment of adrenocortical carcinoma 50
Immunotherapy failure in adrenocortical cancer: Where next? 50
Phase II study of weekly paclitaxel and sorafenib as second/third line therapy in patients with adrenocortical carcinoma. 48
Molecular mechanisms of mitotane action in adrenocortical cancer based on in vitro studies 46
Chemotherapy 42
What is the optimal duration of adjuvant mitotane therapy in adrenocortical carcinoma? An unanswered question 40
Gemcitabine-based chemotherapy in adrenocortical carcinoma: A multicenter study of efficacy and predictive factors 39
Levoketoconazole in the Treatment of Patients With Cushing's Syndrome and Diabetes Mellitus: Results From the SONICS Phase 3 Study 35
Urine Steroid Metabolomics as a Novel Tool for Detection of Recurrent Adrenocortical Carcinoma 27
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study 20
New findings on presentation and outcome of patients with adrenocortical cancer: results from a national cohort study 20
The management of post-operative disease recurrence in patients with adrenocortical carcinoma: a retrospective study in 106 patients 12
Adrenal cortical carcinoma: mitotane and beyond 10
Totale 4.650
Categoria #
all - tutte 10.331
article - articoli 0
book - libri 0
conference - conferenze 652
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.983


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019145 0 0 0 0 0 0 0 0 8 35 76 26
2019/2020575 21 20 23 51 30 71 55 80 90 56 33 45
2020/2021689 45 46 64 38 40 38 60 60 36 68 73 121
2021/2022960 62 44 58 94 78 50 55 70 55 117 168 109
2022/20231.195 106 102 43 114 73 207 79 80 145 51 103 92
2023/2024685 88 129 66 75 88 84 56 90 9 0 0 0
Totale 4.650